Статті в журналах з теми "Heterologous prime-boost"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Heterologous prime-boost".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Lu, Shan. "Heterologous prime–boost vaccination." Current Opinion in Immunology 21, no. 3 (June 2009): 346–51. http://dx.doi.org/10.1016/j.coi.2009.05.016.
Повний текст джерелаPan, Chien-Hsiung, Hui-mei Hu, Yu-Ju Hsiao, and Sze-Hsien Wu. "Heterologous prime-boost vaccination with DNA vaccine and recombinant subunit containing four serotypes of dengue virus envelope protein domain III elicits neutralizing antibodies and specific T-cell responses (P4327)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 123.27. http://dx.doi.org/10.4049/jimmunol.190.supp.123.27.
Повний текст джерелаTang, Xian, and Zhiwei Chen. "Heterologous immunization induces potent anti-SIV immunity with qualitative and quantitative improvements (53.22)." Journal of Immunology 186, no. 1_Supplement (April 1, 2011): 53.22. http://dx.doi.org/10.4049/jimmunol.186.supp.53.22.
Повний текст джерелаZHANG, G., V. T. T. HUONG, B. BATTUR, J. ZHOU, H. ZHANG, M. LIAO, O. KAWASE, et al. "A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity againstToxoplasma gondiiinfection in mice." Parasitology 134, no. 10 (May 17, 2007): 1339–46. http://dx.doi.org/10.1017/s0031182007002892.
Повний текст джерелаGarg, Ishan, Abu Baker Sheikh, Suman Pal, and Rahul Shekhar. "Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review." Infectious Disease Reports 14, no. 4 (July 20, 2022): 537–46. http://dx.doi.org/10.3390/idr14040057.
Повний текст джерелаFolegatti, Pedro M., Amy Flaxman, Daniel Jenkin, Rebecca Makinson, Lucy Kingham-Page, Duncan Bellamy, Fernando Ramos Lopez, et al. "Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies." Vaccines 9, no. 3 (March 16, 2021): 262. http://dx.doi.org/10.3390/vaccines9030262.
Повний текст джерелаCarlétti, Dyego, Denise Morais da Fonseca, Ana Flávia Gembre, Ana Paula Masson, Lívia Weijenborg Campos, Luciana C. C. Leite, Andréa Rodrigues Pires, et al. "A Single Dose of a DNA Vaccine Encoding Apa Coencapsulated with 6,6′-Trehalose Dimycolate in Microspheres Confers Long-Term Protection against Tuberculosis in Mycobacterium bovis BCG-Primed Mice." Clinical and Vaccine Immunology 20, no. 8 (June 5, 2013): 1162–69. http://dx.doi.org/10.1128/cvi.00148-13.
Повний текст джерелаDai, Ming-Shen, Ren-In You, Yu-Feng Hsieh, Kai-Yu Lo, Huey-Kang Sytwu, Georges Vassaux, and Tsu-Yi Chao. "Early Treg suppression by a Listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer (165.49)." Journal of Immunology 186, no. 1_Supplement (April 1, 2011): 165.49. http://dx.doi.org/10.4049/jimmunol.186.supp.165.49.
Повний текст джерелаSantra, Sampa, Yue Sun, Jenny G. Parvani, Valerie Philippon, Michael S. Wyand, Kelledy Manson, Alicia Gomez-Yafal, et al. "Heterologous Prime/Boost Immunization of Rhesus Monkeys by Using Diverse Poxvirus Vectors." Journal of Virology 81, no. 16 (June 6, 2007): 8563–70. http://dx.doi.org/10.1128/jvi.00744-07.
Повний текст джерелаKaku, Chengzi I., Elizabeth R. Champney, Johan Normark, Marina Garcia, Carl E. Johnson, Clas Ahlm, Wanda Christ, et al. "Broad anti–SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination." Science 375, no. 6584 (March 4, 2022): 1041–47. http://dx.doi.org/10.1126/science.abn2688.
Повний текст джерелаShaw, Robert H., Arabella Stuart, Melanie Greenland, Xinxue Liu, Jonathan S. Nguyen Van-Tam, and Matthew D. Snape. "Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data." Lancet 397, no. 10289 (May 2021): 2043–46. http://dx.doi.org/10.1016/s0140-6736(21)01115-6.
Повний текст джерелаMichael, Nelson L. "Simplified steps to heterologous prime-boost HIV vaccine development?" Journal of Clinical Investigation 129, no. 11 (September 30, 2019): 4572–73. http://dx.doi.org/10.1172/jci132440.
Повний текст джерелаGu, Yuan, Bin Zhan, Yaping Yang, Xiaodi Yang, Xi Zhao, Lei Wang, Jing Yang, Kuo Bi, Yunyun Wang, and Xinping Zhu. "Protective Effect of a Prime-Boost Strategy with the Ts87 Vaccine againstTrichinella spiralisInfection in Mice." BioMed Research International 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/326860.
Повний текст джерелаHofer, Tamara, Matteo Rossi, Susanna Carboni, Wilma Di Berardino Besson, Dorothee von Laer, Guido Wollmann, Madiha Derouazi, and Marie-Laure Santiago-Raber. "Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect." Cancers 13, no. 23 (December 3, 2021): 6107. http://dx.doi.org/10.3390/cancers13236107.
Повний текст джерелаXiao, Minglu, Luoyingzi Xie, Guoshuai Cao, Shun Lei, Pengcheng Wang, Zhengping Wei, Yuan Luo, et al. "CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy." Journal for ImmunoTherapy of Cancer 10, no. 5 (May 2022): e004022. http://dx.doi.org/10.1136/jitc-2021-004022.
Повний текст джерелаde Alencar, Bruna C. G., Pedro M. Persechini, Filipe A. Haolla, Gabriel de Oliveira, Jaline C. Silverio, Joseli Lannes-Vieira, Alexandre V. Machado, Ricardo T. Gazzinelli, Oscar Bruna-Romero, and Mauricio M. Rodrigues. "Perforin and Gamma Interferon Expression Are Required for CD4+ and CD8+ T-Cell-Dependent Protective Immunity against a Human Parasite, Trypanosoma cruzi, Elicited by Heterologous Plasmid DNA Prime-Recombinant Adenovirus 5 Boost Vaccination." Infection and Immunity 77, no. 10 (August 3, 2009): 4383–95. http://dx.doi.org/10.1128/iai.01459-08.
Повний текст джерелаLemckert, Angelique A. C., Shawn M. Sumida, Lennart Holterman, Ronald Vogels, Diana M. Truitt, Diana M. Lynch, Anjali Nanda, et al. "Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity." Journal of Virology 79, no. 15 (August 1, 2005): 9694–701. http://dx.doi.org/10.1128/jvi.79.15.9694-9701.2005.
Повний текст джерелаTenbusch, Matthias, Sofie Schumacher, Emanuel Vogel, Alina Priller, Jürgen Held, Philipp Steininger, Stephanie Beileke, et al. "Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2." Lancet Infectious Diseases 21, no. 9 (September 2021): 1212–13. http://dx.doi.org/10.1016/s1473-3099(21)00420-5.
Повний текст джерелаIkeno, Daisuke, Kazuhiko Kimachi, Yasuhiro Kudo, Shuro Goto, Shigeyuki Itamura, Takato Odagiri, Masato Tashiro, and Yoichiro Kino. "A prime–boost vaccination of mice with heterologous H5N1 strains." Vaccine 27, no. 23 (May 2009): 3121–25. http://dx.doi.org/10.1016/j.vaccine.2009.01.007.
Повний текст джерелаRühl, Julia, Carmen Citterio, Christine Engelmann, Tracey Haigh, Andrzej Dzionek, Johannes Dreyer, Rajiv Khanna, et al. "Heterologous prime-boost vaccination protects against EBV antigen–expressing lymphomas." Journal of Clinical Investigation 129, no. 5 (April 15, 2019): 2071–87. http://dx.doi.org/10.1172/jci125364.
Повний текст джерелаLiu, Jinyan, Bonnie A. Ewald, Diana M. Lynch, Matthew Denholtz, Peter Abbink, Angelique A. C. Lemckert, Angela Carville, et al. "Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys." Journal of Virology 82, no. 10 (March 12, 2008): 4844–52. http://dx.doi.org/10.1128/jvi.02616-07.
Повний текст джерелаMeurisse, Marjan, Lucy Catteau, Joris A. F. van Loenhout, Toon Braeye, Laurane De Mot, Ben Serrien, Koen Blot, et al. "Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium." Vaccines 11, no. 2 (February 7, 2023): 378. http://dx.doi.org/10.3390/vaccines11020378.
Повний текст джерелаDangi, Tanushree, Nicole Palacio, Sarah Sanchez, Mincheol Park, Jacob Class, Lavanya Visvabharathy, Thomas Ciucci, Igor J. Koralnik, Justin Richner, and Pablo Penaloza Macmaster. "Cross-protection by SARS vaccines is improved by booster vaccination." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 125.21. http://dx.doi.org/10.4049/jimmunol.208.supp.125.21.
Повний текст джерелаGola, Anita, Adam A. Walters, Stefan Uderhardt, Ahmed M. Salman, Benedict R. Halbroth, Shahid M. Khan, Chris J. Janse, Ronald N. Germain, Alexandra J. Spencer, and Adrian VS Hill. "Prime and Target Immunization Protects Against Liver-Stage Malaria." Journal of Immunology 198, no. 1_Supplement (May 1, 2017): 199.13. http://dx.doi.org/10.4049/jimmunol.198.supp.199.13.
Повний текст джерелаSuphanchaimat, Rapeepong, Natthaprang Nittayasoot, Chuleeporn Jiraphongsa, Panithee Thammawijaya, Punsapach Bumrungwong, Atthavit Tulyathan, Nontawit Cheewaruangroj, Chakkarat Pittayawonganon, and Piyanit Tharmaphornpilas. "Real-World Effectiveness of Mix-and-Match Vaccine Regimens against SARS-CoV-2 Delta Variant in Thailand: A Nationwide Test-Negative Matched Case-Control Study." Vaccines 10, no. 7 (July 5, 2022): 1080. http://dx.doi.org/10.3390/vaccines10071080.
Повний текст джерелаMüller-Hilke, Brigitte, Franz Mai, Michael Müller, Johann Volzke, and Emil C. Reisinger. "Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2." Vaccines 10, no. 2 (February 17, 2022): 322. http://dx.doi.org/10.3390/vaccines10020322.
Повний текст джерелаThorner, Anna R., Angelique A. C. Lemckert, Jaap Goudsmit, Diana M. Lynch, Bonnie A. Ewald, Matthew Denholtz, Menzo J. E. Havenga, and Dan H. Barouch. "Immunogenicity of Heterologous Recombinant Adenovirus Prime-Boost Vaccine Regimens Is Enhanced by Circumventing Vector Cross-Reactivity." Journal of Virology 80, no. 24 (October 11, 2006): 12009–16. http://dx.doi.org/10.1128/jvi.01749-06.
Повний текст джерелаKim, Dong-In, Seo Jin Lee, Soonju Park, Paul Kim, Sun Min Lee, Nakyung Lee, David Shum, Dong Ho Kim, and Eui Ho Kim. "Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19." Vaccines 10, no. 11 (November 4, 2022): 1864. http://dx.doi.org/10.3390/vaccines10111864.
Повний текст джерелаHo, Tzu-Chuan, Yi-Ming Arthur Chen, Hung-Pin Chan, Chin-Chuan Chang, Kuo-Pin Chuang, Che-Hsin Lee, Cheng-Hui Yuan, Yu-Chang Tyan, and Ming-Hui Yang. "The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2." Vaccines 9, no. 10 (October 11, 2021): 1163. http://dx.doi.org/10.3390/vaccines9101163.
Повний текст джерелаMollenkopf, Hans Joachim, Leander Grode, Jens Mattow, Maik Stein, Peggy Mann, Bernhard Knapp, Jeffrey Ulmer, and Stefan H. E. Kaufmann. "Application of Mycobacterial Proteomics to Vaccine Design: Improved Protection by Mycobacterium bovis BCG Prime-Rv3407 DNA Boost Vaccination against Tuberculosis." Infection and Immunity 72, no. 11 (November 2004): 6471–79. http://dx.doi.org/10.1128/iai.72.11.6471-6479.2004.
Повний текст джерелаParys, Anna, Elien Vandoorn, Koen Chiers, Katharina Passvogel, Walter Fuchs, Thomas C. Mettenleiter, and Kristien Van Reeth. "Exploring Prime-Boost Vaccination Regimens with Different H1N1 Swine Influenza A Virus Strains and Vaccine Platforms." Vaccines 10, no. 11 (October 29, 2022): 1826. http://dx.doi.org/10.3390/vaccines10111826.
Повний текст джерелаXing, Zhou, and Thomas James Charters. "Heterologous boost vaccines for bacillus Calmette–Guérin prime immunization against tuberculosis." Expert Review of Vaccines 6, no. 4 (August 2007): 539–46. http://dx.doi.org/10.1586/14760584.6.4.539.
Повний текст джерелаMoore, Anne C., and Adrian V. S. Hill. "Progress in DNA-based heterologous prime-boost immunization strategies for malaria." Immunological Reviews 199, no. 1 (June 2004): 126–43. http://dx.doi.org/10.1111/j.0105-2896.2004.00138.x.
Повний текст джерелаLiu, J., H. Li, M. J. Iampietro, and D. H. Barouch. "Accelerated Heterologous Adenovirus Prime-Boost SIV Vaccine in Neonatal Rhesus Monkeys." Journal of Virology 86, no. 15 (May 16, 2012): 7829–35. http://dx.doi.org/10.1128/jvi.00512-12.
Повний текст джерелаSchneider, Jorg, Sarah C. Gilbert, Carolyn M. Hannan, Pilar Degano, Eric Prieur, Eric G. Sheu, Magdalena Plebanski, and Adrian V. S. Hill. "Induction of CD8+ T cells using heterologous prime-boost immunisation strategies." Immunological Reviews 170, no. 1 (August 1999): 29–38. http://dx.doi.org/10.1111/j.1600-065x.1999.tb01326.x.
Повний текст джерелаSantra, Sampa, Yue Sun, Birgit Korioth-Schmitz, Julie Fitzgerald, Cherie Charbonneau, Giannina Santos, Michael S. Seaman, et al. "Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors." Vaccine 27, no. 42 (September 2009): 5837–45. http://dx.doi.org/10.1016/j.vaccine.2009.07.050.
Повний текст джерелаAbel, Kristina, Lisa Strelow, Yujuan Yue, Meghan K. Eberhardt, Kimberli A. Schmidt, and Peter A. Barry. "A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus." Vaccine 26, no. 47 (November 2008): 6013–25. http://dx.doi.org/10.1016/j.vaccine.2008.07.103.
Повний текст джерелаHe, Ran. "Efficient control of chronic LCMV infection by CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model." Journal of Immunology 198, no. 1_Supplement (May 1, 2017): 123.10. http://dx.doi.org/10.4049/jimmunol.198.supp.123.10.
Повний текст джерелаMichiels, Yves, Nadhira Houhou-Fidouh, Gilles Collin, Jérôme Berger, and Evelyne Kohli. "Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient." Vaccines 9, no. 10 (October 6, 2021): 1140. http://dx.doi.org/10.3390/vaccines9101140.
Повний текст джерелаRaposo, Francisco, and Giuseppe Lippi. "Antibody response induced by the boost overdose during COVID-19 heterologous prime-boost vaccination strategy." Clinica Chimica Acta 523 (December 2021): 201–4. http://dx.doi.org/10.1016/j.cca.2021.09.022.
Повний текст джерелаKim, Jaejo, Seung-Heon Lee, Ha-Hyun Kim, Jong-Hyeon Park, and Choi-Kyu Park. "Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs." Vaccines 11, no. 3 (February 25, 2023): 551. http://dx.doi.org/10.3390/vaccines11030551.
Повний текст джерелаBenning, Louise, Maximilian Töllner, Asa Hidmark, Matthias Schaier, Christian Nusshag, Florian Kälble, Paula Reichel, et al. "Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers." Vaccines 9, no. 8 (August 4, 2021): 857. http://dx.doi.org/10.3390/vaccines9080857.
Повний текст джерелаHovav, Avi-Hai, Mark J. Cayabyab, Michael W. Panas, Sampa Santra, John Greenland, Ralf Geiben, Barton F. Haynes, William R. Jacobs, and Norman L. Letvin. "Rapid Memory CD8+ T-Lymphocyte Induction through Priming with Recombinant Mycobacterium smegmatis." Journal of Virology 81, no. 1 (October 18, 2006): 74–83. http://dx.doi.org/10.1128/jvi.01269-06.
Повний текст джерелаBarouch, Dan H., Paul F. McKay, Shawn M. Sumida, Sampa Santra, Shawn S. Jackson, Darci A. Gorgone, Michelle A. Lifton, et al. "Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines." Journal of Virology 77, no. 16 (August 15, 2003): 8729–35. http://dx.doi.org/10.1128/jvi.77.16.8729-8735.2003.
Повний текст джерелаWalther, Michael, Fiona M. Thompson, Susanna Dunachie, Sheila Keating, Stephen Todryk, Tamara Berthoud, Laura Andrews, et al. "Safety, Immunogenicity, and Efficacy of Prime-Boost Immunization with Recombinant Poxvirus FP9 and Modified Vaccinia Virus Ankara Encoding the Full-Length Plasmodium falciparum Circumsporozoite Protein." Infection and Immunity 74, no. 5 (May 2006): 2706–16. http://dx.doi.org/10.1128/iai.74.5.2706-2716.2006.
Повний текст джерелаOrlinger, Klaus Karl, Weldy V. Bonilla, Sandra M. Kallert, Nicole Kirchhammer, Anna-Friederike Marx, Magdalena Krzyzaniak, Sarah Schmidt, et al. "Arenavirus-based vector platform for massive tumor self-antigen-specific CD8 T cell immunity." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e14297-e14297. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14297.
Повний текст джерелаKim, Silvia, Jeffrey Currier, Josephine Cox, Jean-Louis Excler, Eddy Sayeed, Merlin Robb, Jerome Kim, Nelson Michael, and Mary Marovich. "Cellular immunogenicity of an Ad35GGRIN+ENV and MVA-CMDR prime-boost vaccine regimen. (42.3)." Journal of Immunology 184, no. 1_Supplement (April 1, 2010): 42.3. http://dx.doi.org/10.4049/jimmunol.184.supp.42.3.
Повний текст джерелаSabarth, Nicolas, M. Keith Howard, Helga Savidis-Dacho, André van Maurik, P. Noel Barrett, and Otfried Kistner. "Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model." Vaccine 28, no. 3 (January 2010): 650–56. http://dx.doi.org/10.1016/j.vaccine.2009.10.105.
Повний текст джерелаValdés, Iris, Lázaro Gil, Yaremis Romero, Jorge Castro, Pedro Puente, Laura Lazo, Ernesto Marcos, María G. Guzmán, Gerardo Guillén, and Lisset Hermida. "The Chimeric Protein Domain III-Capsid of Dengue Virus Serotype 2 (DEN-2) Successfully Boosts Neutralizing Antibodies Generated in Monkeys upon Infection with DEN-2." Clinical and Vaccine Immunology 18, no. 3 (January 5, 2011): 455–59. http://dx.doi.org/10.1128/cvi.00382-10.
Повний текст джерелаFiander, A. N., A. J. Tristram, E. J. Davidson, A. E. Tomlinson, S. Man, P. J. Baldwin, J. C. Sterling, and H. C. Kitchener. "Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial." International Journal of Gynecologic Cancer 16, no. 3 (2006): 1075–81. http://dx.doi.org/10.1136/ijgc-00009577-200605000-00020.
Повний текст джерела